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Is the association of birth weight with premenopausal breast
cancer risk mediated through childhood growth?
I dos Santos Silva*,1, BL De Stavola1, RJ Hardy2, DJ Kuh2, VA McCormack1 and MEJ Wadsworth2
1Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK; 2MRC
National Survey of Health and Development, Department of Epidemiology and Public Health, University College, London WC1E 6BT, UK
Several studies have found positive associations between birth weight and breast cancer risk at premenopausal ages. The mechanisms
underlying this association are not known, but it is possible that it may be mediated through childhood growth. We examined data
from a British cohort of 2176 women born in 1946 and for whom there were prospective measurements of birth weight and of body
size throughout life. In all, 59 breast cancer cases occurred during follow-up, 21 of whom were known to be premenopausal. Women
who weighed at least 4 kg at birth were five times (relative risk (RR)¼ 5.03; 95% confidence interval¼ 1.13, 22.5) more likely to
develop premenopausal breast cancer than those who weighed less than 3 kg (P-value for linear trend¼ 0.03). This corresponded to
an RR of 2.31 (0.95, 5.64) per 1 kg increase in birth weight. Birth weight was also a predictor of postnatal growth, that is, women who
were heavy at birth remained taller and heavier throughout their childhood and young adulthood. However, the effect of birth weight
on premenopausal breast cancer risk was only reduced slightly after simultaneous adjustment for height and body mass index (BMI) at
age 2 years and height and BMI velocities throughout childhood and adolescence (adjusted RR¼ 1.94 (0.74, 5.14) per 1 kg increase in
birth weight). The pathways through which birth weight is associated with premenopausal breast cancer risk seem to be largely
independent of those underlying the relation of postnatal growth to risk.
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It has been proposed that breast cancer may have a prenatal origin
(Trichopoulos, 1990). Several studies have since used birth weight
as a marker of the in utero environment to investigate this. Positive
linear relationships between birth weight and breast cancer risk,
particularly at premenopausal ages have been reported (Michels
et al, 1996; De Stavola et al, 2000; Hu¨binette et al, 2001; Kaijser
et al, 2001; Vatten et al, 2002; McCormack et al, 2003), while J-
shaped associations were found in other studies (Ekbom et al,
1992; Sanderson et al, 1996; Innes et al, 2000; Titus-Ernstoff et al,
2002).
The pathways through which the foetal environment may
influence breast cancer risk are not known. Birth size is a
predictor of postnatal growth and adult height (Srensen et al,
1999; Tuvemo et al, 1999; dos Santos Silva et al, 2002), and both
age at menarche (Hsieh et al, 1990) and adult height (van den
Brandt et al, 2000) are well-established risk factors for breast
cancer. Thus, it is conceivable that the observed association might
just be a correlate of the relation of postnatal growth with risk.
Proper examination of this hypothesis has been hampered by the
lack of detailed prospective data on growth throughout childhood
and adolescence. Recall, by the women themselves or their
mothers, of body size measurements early in life are likely to be
inaccurate.
The Medical Research Council National Survey of Health and
Development is a cohort of over 2000 women who have been
followed since their birth in 1946 (Wadsworth et al, 2003). This
cohort is unique in that it includes prospective measurements not
only of birth weight but also of height and weight throughout
childhood, adolescence and adulthood, as well as data on adult life
risk factors for breast cancer. In earlier analyses of data from this
cohort, we reported a positive association between birth weight
and breast cancer risk and found that cases tended to be taller and
slimmer throughout childhood than noncases (De Stavola et al,
2000). Fast height gains at ages 4–7 and 11– 15 years, and steep
decreases in body mass index (BMI) at ages 2 –4 years, were
identified as the strongest positive predictors of risk (De Stavola
et al, 2004). In the present analysis, we have investigated whether
the effect of birth weight on risk is mediated through growth in
childhood and adolescence.
MATERIAL AND METHODS
The National Survey of Health and Development is a socially
stratified cohort of 5362 single legitimate live-births that occurred
in Britain during the week 3 –9 March 1946 and who have since
been followed up. Most of the follow-up contacts were home
interviews (Wadsworth et al, 2003), but a postal health ques-
tionnaire was also sent annually between 1993 and 2000 (from
when cohort members were aged 47–54 years) to all women in the
cohort with whom there was still direct contact (Kuh and Hardy,
2003). These follow-up contacts provided information on maternal
age at birth, birth order, father’s social class and reproductive-
related variables, including menopausal status and date of
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menopause (defined retrospectively after 12 months of amenor-
rhoea), hysterectomy (or bilateral oophorectomy) and hormone
replacement therapy (HRT) use. Height and weight were measured
prospectively throughout childhood (at ages 2, 4, 6, 7, 11 and 14/15
years) and adulthood (at ages 36, 43 and 53 years) using
standardised procedures. Leg length was derived by subtracting
sitting height from standing height measured at age 43 years. Birth
weight data were obtained from medical records within a few
weeks of delivery. Age at menarche was reported by the girls’
mothers when the girls were 15 years old or, when this was not
possible, by the respondents in the postal questionnaire at age 48
years (n¼ 210). Self-reported data on breast cancer diagnosis were
collected through the various follow-up contacts. In addition, in
1971, when the National Health Service Central Register (NHSCR)
started to record cancers occurring in the UK population, all
cohort members (including those with whom there was no longer
direct contact) were ‘flagged’ at the NHSCR to provide notification
of cancers, deaths and emigrations for the cohort.
Of the 2547 women in the birth cohort, 2176 (85%) who were
known to be still alive on 1 January 1971 and for whom there was
birth weight information and at least one height measurement in
childhood, were included in the present analysis. Of the 371 who
were excluded, 114 (31%) had died from nonbreast cancer causes
and 176 (47%) had emigrated before 1971 and were no longer in
contact with the study. A further 70 (19%) did not have any height
measurements between ages 2 and 15 years and 11 (3%) had no
birth weight data.
Approval for the study was obtained from all relevant ethics
committees.
Statistical methods
Breast cancer relative risks (RRs) by birth weight were estimated as
rate ratios using a Cox regression model (Clayton and Hills, 1993),
where age defined the time scale. Follow-up was analysed from 1
January 1971 to the earliest of date of breast cancer diagnosis, date
of death or emigration, or 31 December 1999 (the last date for
which the NHSCR cancer registration data were considered to be
complete at the time of this analysis). The effect of birth weight on
breast cancer risk was also examined separately at premenopausal
ages (the women in the cohort are still too young to allow separate
analysis at natural postmenopausal ages). Analyses at premeno-
pausal ages were restricted to 1513 women who participated in
recent follow-up contacts when information on menopausal status
was collected. The premenopausal follow-up of these women was
defined from 1 January 1971 to the earliest of: breast cancer
diagnosis, date of natural menopause, date of hysterectomy (or
bilateral oophorectomy), start of HRT or date of last completed
questionnaire (up to 1999).
Birth weight was analysed both as a continuous and as a
categorical variable (categorised into four groups: o3.000, 3.000 –
3.499, 3.500–3.999, X4.000 kg). To assess whether the effect of
birth weight on breast cancer incidence was mediated through
postnatal growth, we fitted models that included birth weight plus
height and BMI throughout childhood and adolescence (at ages 2–
15 years) and height at age 36 years, used as a proxy for the final
height achieved at the end of the adolescent growth spurt. These
anthropometric variables were specified either as age-specific
attained values (reflecting cumulative growth up to a given age) or
as velocities between consecutive ages (capturing growth during
particular age intervals). For some cohort members, childhood
anthropometric data were not available at all follow-up contacts
and so a multiple imputation procedure (Schafer, 1999) was used
to fill in these values and obtain estimates of the birth weight effect
controlled for childhood growth that were based on the whole
cohort rather than the smaller subset of complete-record subjects.
A full description of the multiple imputation procedure used is
given elsewhere (De Stavola et al, 2004). Briefly, it consisted of first
modelling the available measurements of height and BMI using
random effects growth models that included maternal height,
father’s social class, birth order, birth weight, age at menarche and
breast cancer incidence as explanatory variables. The model’s
parameters were then used to define the data distribution from
which to impute the missing values. To fully account for the data
variability, and assuming that data were missing at random, five
sets of imputations were carried out and the results summarised as
described by Schafer (1999). In models that included imputed
anthropometric data, RRs were estimated as odds ratios derived
from logistic regression as current multiple imputation methods
cannot deal satisfactory with Cox’s regression (Vach and Blettner,
2000). Owing to the completeness of the follow-up information,
logistic regression produced similar odds ratios to the rate ratios
obtained with Cox’s regression. All RRs in Table 2 were estimated
from logistic regression models. All tests of statistical significance
are two-sided.
RESULTS
In all, 59 breast cancer cases occurred during the follow-up period.
The median age at incidence was 49 years (25th and 75th
percentiles: 45 and 52 years). The median age at last follow-up
for the remaining 2117 women was 53 years (25th and 75th
percentiles: 53 and 53 years; only 3.6% were lost to follow-up, due
to emigration, before reaching age 50 years). A total of 21 cases
were known to be premenopausal (with ages of diagnosis ranging
from 36 to 51 years) and nine were known to be natural
postmenopausal at the time of diagnosis of breast cancer (age at
diagnosis: 46– 53 years). A further 12 had undergone hysterectomy
before diagnosis or reported to have been postmenopausal at the
time of diagnosis but did not indicate whether the menopause was
natural. No information on menopausal status was available for the
remaining 17 women. Anthropometric measures in childhood were
available at each age between 76 and 90% and in adulthood for
about 75% of all eligible women in the cohort. The probability that
a measure was missing was unrelated to the woman’s values at
later ages or to her subsequent risk of breast cancer. For instance,
having missing height data at age 7 years was not associated with
adult height (P¼ 0.24) or occurrence of breast cancer (P¼ 0.67).
Table 1 shows a strong effect of birth weight on premenopausal
breast cancer incidence with a steady positive trend across the four
birth weight categories (P-value for linear trend¼ 0.03). Women
who weighed at least 4 kg at birth were five (RR¼ 5.03; 95%
confidence interval (CI)¼ 1.13, 22.5) times more likely to develop
premenopausal breast cancer than those who weighed less than
3 kg. This corresponded to a rate ratio of 2.37 (95% CI¼ 0.97, 5.80)
per 1 kg increase in birth weight. The effect of birth weight on all-
ages breast cancer incidence was in the same direction, but was of
a much smaller magnitude (Table 1).
Birth weight was also a predictor of height and BMI trajectories
throughout childhood and young adulthood (Figure 1), with
women who weighed 3.500 kg or more being taller and heavier
throughout their childhood relative to those who were lighter at
birth. Adult height (at ages 36 years), as a marker of the final
height achieved at the end of the adolescent growth spurt, was
associated with premenopausal breast cancer, rates increasing by
80% per every standard deviation (s.d. (about 6 cm)) increase in
height (P¼ 0.02). In contrast, adult BMI (at age 36 years) was
inversely related to premenopausal breast cancer rates (33%
reduction in rates per every s.d. (about 4 kg m2) increase in BMI),
but the association was not statistically significant (P¼ 0.20).
Similar relationships were observed with all-ages breast cancer.
The effect of birth weight on risk was only slightly reduced after
adjustment for age-specific attained heights or BMIs (or interval-
specific velocities) (Table 2). Results for all women with known
menopausal status (n¼ 1513), using data derived from the
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multiple imputation procedure, showed that simultaneous adjust-
ment for attained height at age 2 years and height velocities
thereafter decreased the RR (as estimated by odds ratio from a
logistic regression model) associated with 1 kg increase in birth
weight from 2.31 (95% CI¼ 0.95, 5.64) to 1.87 (95% CI¼ 0.73,
4.78), whereas simultaneous adjustment for attained BMI at age 2
years and subsequent BMI velocities had little impact on the
magnitude of the birth weight effect (RR¼ 2.38 (95% CI¼ 0.96,
5.91)). When both height and BMI at age 2 years and their interval-
specific velocities were taken into account simultaneously, the
magnitude of the birth weight effect decreased only slightly from
its original value of 2.31 to 1.94 (95% CI¼ 0.74, 5.14). Similar
results were obtained using only the subsets of women for whom
the relevant measurements were available, although they were
based on much smaller numbers (Table 2).
Simultaneous adjustment for height and BMI at age 2 years and
for height and BMI velocities throughout childhood and adoles-
cence did not change the magnitude of the birth weight effect on
all-ages breast cancer (the RR associated with 1 kg increase in birth
weight before and after adjustment for growth in childhood was
1.46 (95% CI¼ 0.87, 2.46) and 1.50 (95% CI¼ 0.85, 2.66),
respectively). Similar results were obtained when the analyses
were restricted to the subset of women for whom measurements
were available at all follow-up contacts.
Further adjustment for adult leg length, a better marker of
growth in childhood than adult height, did not affect the
magnitude of the birth weight effect on premenopausal breast
cancer risk in the subset of women for whom this measure was
available (n¼ 720) (the RR adjusted for height and BMI velocities
during childhood associated with 1 kg increase in birth weight
before and after further adjustment for leg length was 2.25 (95%
CI¼ 0.62, 8.10) and 2.20 (95% CI¼ 0.61, 7.98), respectively).
Similarly, the magnitude of the birth weight effect did not change
with further adjustment for age at menarche in the group of
women with known age at menarche (n¼ 766) (the RR adjusted for
height and BMI velocities associated with 1 kg increase in birth
weight before and after further adjustment for age at menarche was
2.74 (95% CI¼ 0.75, 9.94) and 2.78 (95% CI 0.77, 10.09),
respectively). Further adjustment for maternal age, birth order,
father’s social class, age at first birth, parity or adult BMI provided
similar results.
DISCUSSION
Main findings
This study revealed a positive association between birth weight
and risk of breast cancer, which was particularly strong at
premenopausal ages. This finding is consistent with the results
of an earlier analysis of data from this cohort and with those
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Figure 1 Mean standardisedw height and BMI by age and birth weight
categories. (wstandardised height at age t years¼ (height at age t
yearsmean (height at age t years))/s.d. (height at age t years); standardised
BMI at age t years¼ (BMI at age t yearsmean (BMI at age t years))/s.d.
(BMI at age t years).
Table 1 Breast cancer incidence rates and age-adjusted rate ratios by birth weight and age
N No. of cases Rate (per 100 000 person-years) Age-adjusted rate ratioa (95% CI) Test for linear trend
Birth weight
Premenopausal ages
Categorical (kg)
o3.000 380 3 34.1 1
3.000–3.499 559 6 46.8 1.37 (0.34, 5.47)
3.500–3.999 469 8 74.0 2.18 (0.58, 8.21)
X4.000 105 4 167.1 5.03 (1.13, 22.47) P¼ 0.03
Per 1 kg increase in birth weight 1513 21 — 2.37 (0.97, 5.80) P¼ 0.06
All ages
Categorical (kg)
o3.000 557 13 83.0 1
3.000–3.499 802 18 80.7 0.98 (0.48, 2.00)
3.500–3.999 652 22 120.2 1.39 (0.69, 2.77)
X4.000 165 6 129.7 1.57 (0.60, 4.13) P¼ 0.21
Per 1 kg increase in birth weight 2176 59 — 1.46 (0.87, 2.46) P¼ 0.15
CI¼ confidence interval. aAs estimated from a Cox regression model (see text – Statistical methods).
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reported by other larger prospective studies (Michels et al, 1996;
McCormack et al, 2003). The main contribution of the present
study, however, was to show that the birth weight– breast cancer
association was only reduced marginally after adjustment for
measures of growth in childhood and adolescence.
Strengths and weaknesses
This cohort is unique in that it includes prospective measurements
not only of birth weight but also of height and weight throughout
life. Incomplete follow-up was minimised because, as well as
having frequent contacts, the cohort has been flagged through
NHSCR since 1971, losses before than being essentially due to non-
breast cancer deaths and emigrations at young ages. The cohort
has remained representative of the native population (Wadsworth
et al, 2003) and the number of identified breast cancer cases was
similar to that expected on the basis of national incidence rates (59
observed, 57.7 expected). One of the limitations of this cohort is
the small number of cases accrued so far. Information on
menopausal status was available for only a subset of women in
the cohort, but reanalyses censoring the information on the whole
cohort at age 51 years, the median age at menopause among those
with known menopausal status, provided similar results.
The value of the birth weight data as a measure of foetal growth
is limited by the fact that this measure reflects both linear growth
and adiposity, and by the lack of gestational age. A recent study
showed stronger associations of premenopausal breast cancer with
birth length than birth weight, which became even stronger after
adjustment for gestational age (McCormack et al, 2003). Birth
length for gestational age has also been shown to be a stronger
predictor of adult height than birth weight for gestational age
(Srensen et al, 1999; Tuvemo et al, 1999). Although birth weight
data may be subject to measurement error this is likely to have
been nondifferential and, hence, it would have led to an
attenuation of the true effect of birth weight on breast cancer risk.
Data on height and weight were collected prospectively
throughout childhood and adulthood. A multiple imputation
procedure was used to replace missing values with imputed ones,
thus allowing all the analyses to be based on data from the whole
cohort rather than restricting them to the various subsets for
whom anthropometric data were available at each relevant age.
Individual anthropometric values are likely to have been affected
by random measurement errors, but the inclusion in the statistical
models of all available (observed and imputed) age-specific
measurements should have provided a more accurate measure of
the underlying growth trajectory for each woman. No measure-
ments were taken between birth and age 2 years, but further
Table 2 Premenopausal breast cancer RRs per 1 kg increase in birth weight before and after adjustment for childhood height and BMI
Observed values Observed and imputed values (Na¼1513, Da¼21)
Controlled for Na Da RRb (95% CI) RRb (95% CI)
None 1513 21 2.31 (0.95, 5.64) 2.31 (0.95, 5.64)
Height
At 2 yrs 1238 19 2.20 (0.84, 5.76) 2.11 (0.85, 5.25)
At 4 yrs 1351 20 2.19 (0.84, 5.70) 2.05 (0.82, 5.11)
At 7 yrs 1347 18 2.19 (0.82, 5.86) 2.07 (0.83, 5.15)
At 11 yrs 1309 18 2.57 (0.97, 6.83) 2.16 (0.88, 5.33)
At 15 yrs 1200 16 2.01 (0.70, 5.77) 2.00 (0.80, 4.98)
Adultc 1345 19 1.97 (0.75, 5.15) 1.92 (0.76, 4.82)
Rate 2–4 yrs 1159 19 2.51 (0.96, 6.61) 2.33 (0.94, 5.76)
Rate 4–7 yrs 1227 18 2.53 (0.94, 6.80) 2.33 (0.95, 5.69)
Rate 7–11 yrs 1239 17 2.78 (1.03, 7.51) 2.32 (0.95, 5.65)
Rate 11–15 yrs 1139 16 2.27 (0.81, 6.32) 2.28 (0.94, 5.58)
Rate 15–adultc 1080 14 2.55 (0.86, 7.55) 2.30 (0.94, 5.61)
At 2 yrs+ratesd 768 13 2.21 (0.63, 7.72) 1.87 (0.73, 4.78)
BMI
At 2 yrs 1184 17 2.30 (0.84, 6.30) 2.44 (0.99, 5.99)
At 4 yrs 1319 20 2.46 (0.97, 6.22) 2.35 (0.96, 5.74)
At 7 yrs 1296 17 2.01 (0.74, 5.49) 2.32 (0.94, 5.71)
At 11 yrs 1292 18 2.86 (1.10, 7.45) 2.44 (1.01, 5.92)
At 15 yrs 1181 15 3.06 (1.08, 8.68) 2.43 (1.00, 5.87)
Rate 2–4 yrs 1092 17 2.14 (0.78, 5.90) 2.36 (0.97, 5.78)
Rate 4–7 yrs 1156 17 2.05 (0.75, 5.62) 2.30 (0.94, 5.62)
Rate 7–11 yrs 1178 16 2.31 (0.82, 6.46) 2.29 (0.94, 5.60)
Rate 11–15 yrs 1108 15 2.80 (0.98, 7.80) 2.32 (0.95, 5.64)
At 2 yrs+ratese 759 13 2.63 (0.81, 8.53) 2.38 (0.96, 5.91)
Height and BMI
At 2 yrs+ratesf 680 11 2.14 (0.53, 8.66) 1.94 (0.74, 5.14)
RR¼ relative risks; CI¼ confidence interval; BMI¼ body mass index; yrs¼ years. aNumber of cohort members (N) and breast cancer cases (D) for whom there was information
on the relevant age-specific anthropometric variable. bRRs as estimated by odds ratios from a logistic regression model (see text – Statistical methods). cHeight at age 36 years as
a proxy for the final height achieved at the end of the adolescent growth spurt. dControlling for height at age 2 years and rates 2–4, 4 –7, 7–11, 11–15 and 15 to adulthood.
eControlling for BMI at age 2 years and rates 2–4, 4 –7, 7–11 and 11–15 years. fControlling for height at age 2 years and rates 2–4, 4 –7, 7–11, 11–15 and 15 to adulthood
and for BMI at age 2 years and rates 2–4, 4–7, 7 –11 and 11–15 years.
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adjustment for the difference between a girl’s standardised rank in
height (or BMI) at age 2 years and her standardised rank in birth
weight, this difference being taken as an indicator of early growth,
did not alter the reported effects of birth weight on breast cancer
risk. Although the available anthropometric data did not allow
calculation of age at peak height velocity, the analysis took into
account velocity of growth in early childhood and age at menarche,
factors known to be closely related to age at peak height velocity
(Tanner, 1989; Luo et al, 2003).
Implications
It has been hypothesised that the observed associations between
birth weight and breast cancer risk may reflect intrauterine
exposure to oestrogens and other biological factors that may
increase the number of stem cells in the breast gland and/or their
proliferation (Trichopoulos, 1990, 2003). Postnatal exposure to
high levels of endogenous oestrogens is known to play an
important role in breast cancer in postmenopausal women (The
Endogenous Hormones and Breast Cancer Collaborative Group,
2002), although the evidence is less consistent in premenopausal
women (Thomas et al, 1997). The levels of endogenous oestrogens
are about 10 times higher in pregnancy than at any other time in a
woman’s life (Yen, 1989) and, therefore, it is conceivable that in
utero exposure to high concentrations of these hormones may
affect the mammary tissue and the risk of malignancy later in life
in the offspring (Trichopoulos, 1990, 2003). Birth weight may also
be associated with breast cancer through its relationship with
postnatal growth (dos Santos Silva et al, 2002; Srensen et al,
1999). The latter interpretation would be consistent with findings
from some (Hankinson et al, 1998; Toniolo et al, 2000), but not all
(Kaaks et al, 2002), prospective studies showing that high serum
levels in adulthood of insulin-like growth factor-I (IGF-I), a
hormone that promotes somatic growth, are associated with an
increased risk and that, similar to the effect of birth weight, the
IGF-I association with breast cancer seems to be particularly
stronger at premenopausal ages. Adult height, however, has been
shown to be associated with both pre- and postmenopausal breast
cancer (van den Brandt et al, 2000), suggesting that birth weight
and adult height may be associated with risk through different
biological mechanisms. In the present study, the magnitude of the
effect of birth weight on premenopausal breast cancer risk did not
change after adjustment for BMI in childhood, but it was slightly
reduced after adjustment for childhood height. Thus, although the
effect of birth weight on risk might, to a small extent, be mediated
through childhood growth, our findings imply that birth weight
affects premenopausal breast cancer risk largely through a separate
biological pathway.
In short, the findings from this study suggest that the
relationship between birth weight and premenopausal breast
cancer risk is largely independent, rather than a correlate of the
association of childhood growth and risk of this tumour.
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